AETERNUM HEALTH, INC.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $13.9K | $47.8K | $38.0K | $15.0K | $20.0K |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $-49.0K | $-59.9K | $-81.4K | $-83.6K | $-80.7K | $-155.6K | $-179.0K | $-195.1K |
| Operating Margin | — | — | — | -599.8% | -168.9% | -409.9% | -1,193.2% | -975.3% |
| Interest Expense | $3.5K | $1.2K | $1.8K | $5.7K | $20.5K | $24.3K | $32.0K | $33.0K |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | $-52.5K | $-61.1K | $-83.2K | $103.6K | $-98.9K | $-240.1K | $-256.9K | $-194.8K |
| Net Margin | — | — | — | 743.4% | -207.1% | -632.4% | -1,712.8% | -974.2% |
| EPS (Basic) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.01 | $-0.01 | $-0.01 |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.01 | $-0.01 | $-0.01 |
| Shares Outstanding (Basic) | 24.6M | 24.6M | 24.6M | 24.6M | 24.6M | 24.6M | 24.6M | 24.5M |
| Shares Outstanding (Diluted) | 24.6M | 24.6M | 24.6M | 32.3M | 24.6M | 24.6M | 32.3M | 32.3M |
| Dividends Per Share | — | — | — | — | — | — | — | — |